Lewis R B, McClure J, Rup B, Niesel D W, Garry R F, Hoelzer J D, Nazerian K, Bose H R
Cell. 1981 Aug;25(2):421-31. doi: 10.1016/0092-8674(81)90060-x.
Non-virus-producing hematopoietic cells transformed in vitro by reticuloendotheliosis virus (REV-T) induce lethal "reticuloendotheliosis" when inoculated into histocompatible chickens. This is the first direct demonstration that an in vivo target cell of an avian acute leukemia virus can be transformed in vitro. The tumorigenic, REV-T-transformed non-virus-producing cells fail to express helper-virus-coded proteins. REV-T transformed tumorigenic cells therefore do not require helper-virus functions. Cells transformed in vivo or in vitro by REV-T have lymphoblastoid morphology and express low levels of terminal-deoxynucleotidyl-transferase activity and bursal-cell determinants. One clone synthesized Ig mu. The preferred target cells for REV-T transformation are therefore immature lymphoid cells that express B-cell determinants. We propose that the unique transforming sequence of REV-T be designated rel (lymphoid).
经网状内皮增生症病毒(REV-T)体外转化的不产生病毒的造血细胞,接种到组织相容性鸡体内时会引发致死性的“网状内皮增生症”。这是首次直接证明禽急性白血病病毒的体内靶细胞可在体外被转化。具有致瘤性的、经REV-T转化的不产生病毒的细胞无法表达辅助病毒编码的蛋白质。因此,经REV-T转化的致瘤细胞不需要辅助病毒功能。体内或体外经REV-T转化的细胞具有淋巴母细胞样形态,表达低水平的末端脱氧核苷酸转移酶活性和法氏囊细胞决定簇。一个克隆合成了Igμ。因此,REV-T转化的首选靶细胞是表达B细胞决定簇的未成熟淋巴细胞。我们提议将REV-T独特的转化序列命名为rel(淋巴细胞)。